BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38103359)

  • 1. Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trial.
    Himle JA; Grogan-Kaylor A; Hiller MA; Mannella KA; Norman LJ; Abelson JL; Prout A; Shunnarah AA; Becker HC; Russman Block SR; Taylor SF; Fitzgerald KD
    Behav Res Ther; 2024 Jan; 172():104458. PubMed ID: 38103359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial.
    Russman Block S; Norman LJ; Zhang X; Mannella KA; Yang H; Angstadt M; Abelson JL; Himle JA; Taylor SF; Fitzgerald KD
    Am J Psychiatry; 2023 Jan; 180(1):89-99. PubMed ID: 36475374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial of OC-Go for Childhood Obsessive-Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment.
    Tuerk PW; McGuire JF; Piacentini J
    Behav Ther; 2024 Mar; 55(2):306-319. PubMed ID: 38418042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder - A non-inferiority randomized controlled trial.
    Exner C; Kleiman A; Haberkamp A; Hansmeier J; Milde C; Glombiewski JA
    J Anxiety Disord; 2024 Jun; 104():102873. PubMed ID: 38729024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
    Kyrios M; Ahern C; Fassnacht DB; Nedeljkovic M; Moulding R; Meyer D
    J Med Internet Res; 2018 Aug; 20(8):e242. PubMed ID: 30089607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder.
    Sampaio T; Lima C; Corregiari F; Bernik M
    Braz J Psychiatry; 2016; 38(4):287-293. PubMed ID: 27798711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive-compulsive disorder: a study protocol for a randomized controlled trial.
    Hoogerwerf E; Greeven A; Goekoop R; Spinhoven P
    Trials; 2024 Jan; 25(1):43. PubMed ID: 38217045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
    Foa EB; Simpson HB; Rosenfield D; Liebowitz MR; Cahill SP; Huppert JD; Bender J; McLean CP; Maher MJ; Campeas R; Hahn CG; Imms P; Pinto A; Powers MB; Rodriguez CI; Van Meter PE; Vermes D; Williams MT
    J Clin Psychiatry; 2015 Apr; 76(4):440-6. PubMed ID: 25375780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K; Franken I; Deen M; van der Heiden C
    Trials; 2019 May; 20(1):277. PubMed ID: 31109349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational Definitions of Treatment Response and Remission in Obsessive-Compulsive Disorder Capture Meaningful Improvements in Everyday Life.
    Mataix-Cols D; Andersson E; Aspvall K; Boberg J; Crowley JJ; de Schipper E; Fernández de la Cruz L; Flygare O; Ivanova E; Lenhard F; Lundström L; Rück C; Serlachius E; Cervin M
    Psychother Psychosom; 2022; 91(6):424-430. PubMed ID: 36382651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.
    Brennan BP; Lee C; Elias JA; Crosby JM; Mathes BM; Andre MC; Gironda CM; Pope HG; Jenike MA; Fitzmaurice GM; Hudson JI
    J Psychiatr Res; 2014 Sep; 56():98-105. PubMed ID: 24909787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: a multiple-baseline across-responses design study.
    Sukhodolsky DG; Gorman BS; Scahill L; Findley D; McGuire J
    J Anxiety Disord; 2013 Apr; 27(3):298-305. PubMed ID: 23602943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
    Rector NA; Richter MA; Katz D; Leybman M
    Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Shannahoff-Khalsa D; Fernandes RY; Pereira CAB; March JS; Leckman JF; Golshan S; Vieira MSR; Polanczyk GV; Miguel EC; Shavitt RG
    Front Psychiatry; 2019; 10():793. PubMed ID: 31780963
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study.
    Feusner JD; Farrell NR; Kreyling J; McGrath PB; Rhode A; Faneuff T; Lonsway S; Mohideen R; Jurich JE; Trusky L; Smith SM
    J Med Internet Res; 2022 May; 24(5):e36431. PubMed ID: 35587365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining clinical severity in adults with obsessive-compulsive disorder.
    Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
    Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.